B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity

Blood

Volumn 92, Issue 3, 1998, Pages 1031-1043

  Zhao, Haixia ^b   Dugas, Nathalie ^b   Mathiot, Claire ^b   Delmer, Alain ^b   Dugas, Bernard ^b   Sigaux, François ^b   Kolb, Jean Pierre ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032147236     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.1031     Document Type: Article

References (61)

1. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL, The French Cooperative Group on CLL: B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 78:1901, 1991
2. Foon KA, Rai KR, Gale RP: Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med 113:525, 1990
3. Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M: CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J Clin Invest 89:1312, 1992
4. Mainou-Fowler T, Prentice AG: Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 21:369, 1996
5. Mainou-Fowler T, Copplestone JA, Prentice AG: Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells. J Clin Pathol 48:482, 1995
6. Fluckiger AC, Briere F, Zurawski G, Bridon JM, Banchereau J: IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells. Immunology 83:397, 1994
7. Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera P, Minty A, Vazquez A, Delfraissy JF: Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022, 1996
8. Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV: Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Br J Haematol 86:169, 1994
9. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK: Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 177:213, 1993
10. Rojas R, Roman J, Torres A, Ramirez R, Carracedo J, Lopez R, Garcia JM, Martin C, Pintado O: Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stage. Leukemia 10:1782, 1996
11. Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV: Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92:97, 1996
12. Corcione A, Corrias MV, Daniele S, Zupo S, Spriano M, Pistoia V: Expression of granulocyte colony-stimulating factor and granulocyte colony-stimulating factor receptor genes in partially overlapping monoclonal B-cell populations from chronic lymphocytic leukemia patients. Blood 87:2861, 1996
13. Corcione A, Pistoia V: B-cell-derived granulocyte-colony stimulating factor (G-CSF). Methods 11:143, 1997
14. Brizard A, Morel F, Lecron JC, Dreyfus B, Brizard F, Barra A, Preud'homme JL: Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23. Leuk Lymphoma 14:311, 1994
15. Jurlander J, Lai CF, Tan J, Chou CC, Geisler CH, Schriber J, Blumenson LE, Narula SK, Baumann H, Caligiuri MA: Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 89:4146, 1997
16. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91, 1994
17. Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85:439, 1993
18. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176:1319, 1992
19. Tangye SG, Raison RL: Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2. Immunol Cell Biol 75:127, 1997
20. Buske C, Gogowski G, Schreiber K, Rave-Frank M, Hiddemann WB: Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Exp Hematol 25:329, 1997
21. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH: Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol 88:268, 1994
22. Jewell AP: Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 21:43, 1996
23. Konig A, Menzel T, Lynen S, Wrazel L, Rosen A, Al-Katib A, Raveche E, Gabrilove JL: Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 11:258, 1997
24. Mainou-Fowler T, Craig VA, Copplestone JA, Hamon MD, Prentice AG: Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood 84:2297, 1994
25. 0. Curr Topics Microbiol Immunol 194:307, 1995
26. Caligaris-Cappio F, Gottardi D, Alfarano A, Stacchini A, Gregoretti MG, Ghia P, Bertero MT, Novarino A, Bergui L: The nature of the B lymphocyte in B-chronic lymphocytic leukemia. Blood Cells 19:601, 1993
27. de long D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM: Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256, 1994
28. Pepper C, Bentley P, Hoy T: Regulation of clinical chemoresistance by bcl-2 and bax oncoprotein in B-cell chronic lymphocytic leukaemia. Br J Haematol 95:513, 1996
29. Osorio LM, De Santiago A, Aguilar-Santelises M, Mellstedt H, Jondal M: CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 89:2833, 1997
30. Gottardi D, Alfarano A, De Leo AM, Stacchini A, Aragno M, Rigo A, Veneri D, Zanotti R, Pizzolo G, Caligaris-Cappio F: In leukaemic CD5 + B cells the expression of BCL-2 gene family is toward protection from apoptosis. Br J Haematol 94:612, 1996
31. Stamler JS: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931, 1994
32. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109, 1991
33. Nathan C: Nitric oxide as a secretory product of mamalian cells. FASEB J 6:3051, 1992
34. Nathan CF, Xie QW: Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915, 1994
35. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137, 1994
36. Reiling N, Kröncke R, Ulmer AJ, Gerdes J, Flad HD, Hauschildt S: Nitric oxide synthase: Expression of the endothelial, Ca2+/ calmodulin dependent isoform in human B and T lymphocytes. Eur J Immunol 26:511, 1996
37. Fournier S, Tran ID, Suter U, Biron G, Delespesse G, Sarfati M: The in vivo expression of type b CD23 mRNA in B chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: Comparison with their normal cellular counterpart. Leuk Res 15:609, 1991
38. Dugas B, Mossalayi DM, Damais C, Kolb JP: Nitric oxide production by human monocytes/macrophages. Evidence for a role of CD23. Immunol Today 16:574, 1995
39. Rector E, Nakajima T, Rocha C, Duncan D, Lestourgeon D, Mitchell RS, Fisher J, Schon A, Delespesse G. Detection and characterization of monoclonal antibodies specific to IgE receptors on human lymphocytes by flow cytometry. Immunology 55:481, 1985
40. Paul-Eugène N, Kolb JP, Sarfati M, Arock M, Ouaaz F, Debré P, Mossalayi MD, Dugas B: Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J Leukoc Biol 57:160, 1995
41. Aubry, JP, Dugas N, Lecoanet-Henchoz S, Ouaaz F, Zhao H, Delfraissy JF, Graber P, Kolb JP, Dugas B, Bonnefoy JY: The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol 159:614, 1997
42. Macdonald RJ, Swift GH, Przybyla AE, Chirgwin JM: Isolation of RNA using guanidinium salts. Methods Enzymol 152:219, 1987
43. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD: The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen. Proc Natl Acad Sci USA 92:7804, 1995
44. Geller DA, Lowenstein CJ, Shapiro RA, Nüssler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491, 1993
45. Asano K, Chee C, Gaston B, Lilly C, Gerard C, Drazen JM, Stamler JS: Constitutive and inducible nitric oxide synthase gene expression, activity and regulation in human lung epithelial cells. Proc Natl Acad Sci USA 91:10089, 1994
46. Roman V, Dugas N, Abadie A, Amirand C, Zhao H, Dugas B, Kolb JP: Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: Stimulation by soluble CD23. Immunology 91:643, 1997
47. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
48. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
49. Weinberg J, Misukonis B, Shami PJ, Mason SN, Sauls WA, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, Haney AF, Granger DL: Human mononuclear phagocyte inductible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184, 1995
50. Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek-Batenburg E, Reutelingsperger CP: Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematologica 98:8, 1997
51. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95:1884, 1995
52. Bellosillo B, Dalmau M, Colomer D, Gil J: Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89:3378, 1997
53. Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M: The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br J Hematol 89:373, 1995
54. Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D: Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 88:4259, 1996
55. Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S: Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Haematologica 81:302, 1996
56. Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH, Dorken B: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur J Immunol 23:702, 1993
57. Mainou-Fowler T, Craig VA, Copplestone AJ, Hamon MD, Prentice AG: Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: The role of bcl-2 and interleukin 4. Leuk Lymphoma 19:301, 1995
58. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV: Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 9:1227, 1995
59. Mannick JB, Miao XQ, Stamler JS. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272:24125, 1997
60. Mentz F, Merle-Beral H, Ouaaz F, Binet JL: Theophylline, a new inducer of apoptosis in B-CLL: Role of cyclic nucleotides. Br J Haematol 90:957, 1995
61. Mentz F, Mossalayi MD, Ouaaz F, Baudet S, Issaly F, Ktorza S, Semichon M, Binet JL, Merle-Beral H: Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 88:2172, 1996